V019-2592 Screening compound: N-[2-(dimethylamino)ethyl]-3-fluoro-N-{[3-(4-fluorophenyl)-5-(4-methylpiperazin-1-yl)-1,2-oxazol-4-yl]methyl}benzamide

V019-2592 Screening compound: N-[2-(dimethylamino)ethyl]-3-fluoro-N-{[3-(4-fluorophenyl)-5-(4-methylpiperazin-1-yl)-1,2-oxazol-4-yl]methyl}benzamide
V019-2592 Screening compound: N-[2-(dimethylamino)ethyl]-3-fluoro-N-{[3-(4-fluorophenyl)-5-(4-methylpiperazin-1-yl)-1,2-oxazol-4-yl]methyl}benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V019-2592
N-[2-(dimethylamino)ethyl]-3-fluoro-N-{[3-(4-fluorophenyl)-5-(4-methylpiperazin-1-yl)-1,2-oxazol-4-yl]methyl}benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V019-2592

Molecular Formula

C26H31F2N5O2 (C26 H31 F2 N5 O2)

Compound Name

N-[2-(dimethylamino)ethyl]-3-fluoro-N-{[3-(4-fluorophenyl)-5-(4-methylpiperazin-1-yl)-1,2-oxazol-4-yl]methyl}benzamide

IUPAC name

N-[2-(dimethylamino)ethyl]-3-fluoro-N-{[3-(4-fluorophenyl)-5-(4-methylpiperazin-1-yl)-12-oxazol-4-yl]methyl}benzamide

SMILES

CN(C)CCN(Cc1c(N2CCN(C)CC2)onc1-c(cc1)ccc1F)C(c1cccc(F)c1)=O

InChI

InChI=1S/C26H31F2N5O2/c1-30(2)11-14-33(25(34)20-5-4-6-22(28)17-20)18-23-24(19-7-9-21(27)10-8-19)29-35-26(23)32-15-12-31(3)13-16-32/h4-10,17H,11-16,18H2,1-3H3

InChI Key

IIKQLYIWAHYRER-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19883234

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

483.56

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.949

Distribution Coefficient, logD

1.570

Water Solubility, LogSw

-3.18

Polar Surface Area

50.068

Acid Dissociation Constant (pKa)

22.54

Base Dissociation Constant (pKb)

8.76

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

38.50

V019-2592 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Antiviral Library (67538 compounds)

Ion Channels Focused Library (26372 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Nervous system
  • Cardiovascular
Targets:
  • Ion Channels

References: we are preparing a list of scientific research reports with V019-2592 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V019-2592?
Check Price and Availability of V019-2592, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V019-2592 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V019-2592
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V019-2592
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V019-2592 available by request